Erik Lium

Directeur/Membre du Conseil chez RENALYTIX PLC

Profil

Dr. Erik Lium is a Chief Commercial Innovation Officer & Executive VP at The Mount Sinai Health System, Inc., an Independent Non-Executive Director at Renalytix Plc, an Investment Review Committee Member at Accelerate Long Island (Venture Capital), an Advisor at Mount Sinai Ambulatory Ventures, Inc, a Chairman at Kantaro Biosciences LLC and a President at Mount Sinai Innovation Partners.
He is on the Board of Directors at Verici Dx Plc, Renalytix Plc, CastleVax, Inc., ELWC Enterprises Ltd. and Trellus Health Plc.
Dr. Lium was previously employed as a President by LabVelocity.
He also served on the board at Amathus Therapeutics, Inc., The University of California, San Francisco, Icahn School of Medicine at Mount Sinai and PreciseDx Ltd. He received his undergraduate degree from Gonzaga University and a doctorate degree from Columbia University College of Physicians & Surgeons.

Postes actifs de Erik Lium

Sociétés	Poste	Début
RENALYTIX PLC	Directeur/Membre du Conseil	01/10/2018
TRELLUS HEALTH PLC	Directeur/Membre du Conseil	-
ELWC Enterprises Ltd.	Directeur/Membre du Conseil	-
CastleVax, Inc.	Directeur/Membre du Conseil	-
Accelerate Long Island (Venture Capital)	Private Equity Investor	01/04/2017
The Mount Sinai Health System, Inc.	Corporate Officer/Principal	01/07/2019
Kantaro Biosciences LLC	Président	-
Mount Sinai Innovation Partners	President	01/03/2014
Mount Sinai Ambulatory Ventures, Inc	Consultant / Advisor	-

Anciens postes connus de Erik Lium

Sociétés	Poste	Fin
░░░░░░ ░░ ░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░ ░░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░ ░░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░░░░░	░░░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-
░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-